- $500.80bn
- $565.10bn
- $61.16bn
Eli Lilly hits record high as healthcare stocks rally
Nvidia-backed Iambic Therapeutics tumbles below IPO price
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Brief: Abbvie Says Risankizumab In Ulcerative Colitis Shows Clinical Remission Rates Of 54.0%-73.1% At Week 96
Brief: AbbVie - Expands Board To Thirteen Directors On October 14, 2026 - SEC Filing
Healthcare stocks rally as investors seek safety amid tech debt worries
US STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Bausch + Lomb CEO Saunders departs, Chairman Appio named interim chief (updated)
Bausch + Lomb CEO Saunders steps down, Chairman Appio appointed interim chief
U.S. STOCKS ON THE MOVE -VF Corp, Biogen, AbbVie
US STOCKS ON THE MOVE-SpaceX, Humana, AbbVie
UBS lifts AbbVie target as focus expands beyond immunology drugs
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom (updated)
Brief: Abbvie's Telisotuzumab Adizutecan Receives Two Breakthrough Therapy Designations From The U.S. FDA For Crc And Nsclc
Factbox: Global healthcare companies invest billions to boost US presence
Genmab at 3-year high after blood cancer drug combination study results